Biomarker-Driven Prescribing in Oncology

《Biomarker-Driven Prescribing in Oncology 》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、ONKOSSTUDYAPHARMACORSERVICEBiomarker-DrivenPrescribinginOncologyMay2014Forquestionsregardingthereportcontentandanalysis,contact:AmyDuval,M.Res.Tel+44.20.7332.7415•E-mailaduval@dresourcesgroup.comOrestisMavroudis-Chocholis,Ph.D.Tel+44.20.7332.7400•E-mailomchocholis@dresour

2、cesgroup.comForquestionsregardingconsulting,contact:JohnM.Lebbos,M.D.Tel+1.781.993.2576•E-mailjlebbos@dresourcesgroup.comForquestionsregardingsales,service,andtechnicalsupport,contact:AmericasEurope,MiddleEast,andAfricaAsiaPacificDaniSmithCarlaDonatoMakikoYoshimotoTel+1.7

3、81.993.2687Tel+44.207.347.5596Tel+81.3.5401.2615E-mailinquiries@dresources.comADECISIONRESOURCESpublicationDECISIONRESOURCESisregisteredintheU.S.PatentandTrademarkOffice.Thismaterial,preparedspecificallyforclientsofDecisionResourcesGroup,isfurnishedinconfidenceandisnottob

4、eduplicatedoutsideofsubscriberorganizationsinanyformwithoutourpriorpermissioninwriting.Theopinionsstatedrepresentourinterpretationandanalysisofinformationgenerallyavailabletothepublicorreleasedbyresponsibleindividualsinthesubjectcompanies.Webelievethatthesourcesofinformat

5、iononwhichourmaterialisbasedarereliableandwehaveappliedourbestprofessionaljudgmenttothedataobtained.Wedonotassumeanyliabilityfortheaccuracy,comprehensiveness,oruseoftheinformationpresented.©2014DecisionResourcesGroup•8NewEnglandExecutivePark•Burlington,MA01803•Tel+1.781.9

6、93.2500•Fax+1.781.993.2550TableofContentsEXECUTIVESUMMARY................................................................1KeyFindings................................................................2KeyMarketChallengesandOpportunities......................................4

7、WhatDotheExpertsSay?.....................................................61.EPIDEMIOLOGYANDPATIENTPOPULATIONS.......................................7Methods....................................................................8DiseaseDefinition..............................

8、............................11BreastCancer......................................................